Infex Therapeutics Limited
Private Limited Company · Macclesfield
ActiveUnited KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-07-31
IXBRL · 141 source facts · 19 selected values
Validation findingsXBRL valid
Accounts to 2025-07-31
IXBRL · 141 source facts · 19 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-08-01 to 2025-07-31
- Extraction status
- complete
- Numeric facts
- 82
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2510_09990238_20250731
- Source archive
- Accounts_Monthly_Data-October2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-07-31
IXBRL · 145 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2024-07-31
IXBRL · 145 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2023-08-01 to 2024-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 86
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3200_09990238_20240731
- Source archive
- Accounts_Monthly_Data-December2024.zip
Accounts to 2023-07-31
IXBRL · 140 source facts · 0 selected values
Not assessedlegacy record
Accounts to 2023-07-31
IXBRL · 140 source facts · 0 selected values
Not assessed
legacy record
- Reporting period
- 2022-08-01 to 2023-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0030_09990238_20230731
- Source archive
- Accounts_Monthly_Data-October2023.zip
Accounts to 2022-07-31
IXBRL · 176 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-07-31
IXBRL · 176 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-08-01 to 2022-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 114
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0111_09990238_20220731
- Source archive
- Accounts_Monthly_Data-October2022.zip
Accounts to 2021-07-31
IXBRL · 154 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-07-31
IXBRL · 154 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-08-01 to 2021-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 94
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0096_09990238_20210731
- Source archive
- Accounts_Monthly_Data-November2021.zip
Accounts to 2020-07-31
IXBRL · 158 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2020-07-31
IXBRL · 158 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2019-08-01 to 2020-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 93
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0083_09990238_20200731
- Source archive
- Accounts_Monthly_Data-October2020.zip
Accounts to 2019-07-31
IXBRL · 136 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2019-07-31
IXBRL · 136 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2018-08-01 to 2019-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 76
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0071_09990238_20190731
- Source archive
- Accounts_Monthly_Data-October2019.zip
Accounts to 2017-07-31
IXBRL · 84 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2017-07-31
IXBRL · 84 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2016-02-05 to 2017-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0049_09990238_20170731
- Source archive
- Accounts_Monthly_Data-November2017.zip
Registered details
09990238- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-02-05
- Jurisdiction
- —
- Registered office
- MERESIDE, ALDERLEY PARK, MACCLESFIELD, SK10 4TG, ENGLAND
Classification
1 SIC codes23107
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
2 matched grantsOptimisation of a novel series of SARS-CoV-2 inhibitorsLeadInnovate UK · Collaborative R&D · 2022-07-01 – 2023-10-31 · with 2 other participants£358,779awarded
Optimisation of a novel series of SARS-CoV-2 inhibitorsLead
Innovate UK · Collaborative R&D · 2022-07-01 – 2023-10-31 · with 2 other participants
£358,779
awarded
Amr Centre Limitedlead£358,779
Liverpool School of Tropical Medicine£335,291
Delivering Integrated Solutions for Human InfectionsInnovate UK · Collaborative R&D · 2020-09-01 – 2027-03-31 · with 5 other participants£4,510,578awarded
Delivering Integrated Solutions for Human Infections
Innovate UK · Collaborative R&D · 2020-09-01 – 2027-03-31 · with 5 other participants
£4,510,578
awarded
Liverpool School of Tropical Medicinelead£12,160,451
INFEX Therapeutics Ltd£4,510,578
University of Liverpool£1,980,255
Royal Liverpool and Broadgreen University Hospitals NHS Trust£0